BridgeBio Oncology Therapeutics Inc.

BBOT | NASDAQ

$4.66

-$0.11 (-2.31%)

At close: Sep 21, 2026, 4:00 PM ET

$4.50

-$0.16 (-3.41%)

Pre-market: Sep 22, 2026, 8:18 AM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021
Cash & Equivalents	373.69M	1.7M	n/a	n/a	n/a
Short-Term Investments	51.77M	n/a	n/a	n/a	n/a
Long-Term Investments	132K	192.45M	n/a	n/a	n/a
Other Long-Term Assets	22.79M	25.13K	332.89K	144.58K	144.28K
Receivables	386K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	-386K	n/a	n/a	n/a	n/a
Total Current Assets	425.46M	1.95M	n/a	n/a	n/a
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	22.92M	192.47M	332.89K	144.58K	144.28K
Total Assets	448.38M	194.42M	332.89K	144.58K	144.28K
Account Payables	1.37M	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	70.1K	43.11K	36.96K
Other Current Liabilities	5.75M	n/a	n/a	n/a	n/a
Total Current Liabilities	35.04M	187.52K	396.46K	166.46K	162.64K
Long-Term Debt	2.24M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	5.52M	n/a	0	n/a
Total Long-Term Liabilities	2.24M	5.52M	n/a	0	n/a
Total Liabilities	37.29M	5.71M	396.46K	166.46K	162.64K
Total Debt	2.77M	n/a	70.1K	43.11K	36.96K
Book Value	411.1M	188.72M	-63.57K	-21.88K	-18.36K
Book Value Per Share	13.20	11.34	0	0	0
Common Stock	8K	192.45M	460	288	288
Retained Earnings	-356.57M	-3.73M	-88.57K	-46.88K	-43.36K
Comprehensive Income	16K	n/a	n/a	n/a	n/a
Shareholders Equity	411.1M	188.72M	-63.57K	-21.88K	-18.36K
Total Investments	51.91M	192.45M	n/a	n/a	n/a